OSCO Presents San Antonio Breast Cancer Symposium® Review

The Oklahoma Society of Clinical Oncology, Inc. would like to invite you to attend our 2023 Spring meeting held at Andrews Academic Tower March 25th.  Optional virtual live attendance available through zoom.  Select the virtual option at registration to receive the zoom link.

Join your colleagues to hear highlights from this state-of-the art symposium on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease. The SABCS® Review is an officially licensed program of the San Antonio Breast Cancer Symposium®.  This virtual symposium is directed towards Hematologists and Oncologists, Nurses, Pharmacists, Physician Assistants and other health care professionals specializing in Oncology.  This meeting will break down the most clinically relevant abstracts from the SABCS annual symposium, providing attendees to hear the latest strategies in oncology education.  Note:  There is no fee for physicians and allied health personnel to attend, but meeting registration is required.  

  • SABCS® Review is an officially licensed program provided through Encore Medical Education.
  • This conference is jointly provided by Postgraduate Institute for Medicine and Oklahoma Society of Clinical Oncology, Inc.
  • This activity has been approved for a maximum of 4 AMA PRA Category 1 Credit(s)™and 4 contact hours for Continuing Nursing Education.

Pharmaceutical Companies interested in Corporate Membership or Exhibiting? Join here →

For more information contact OSCO Executive Director Kathleen Musson by e-mail to kmussonokc@gmail.com

Show Agenda
  • 7:00 AM (CDT)
    Virtual Exhibitor Booths Set-up
  • 7:15 AM (CDT)
    Continental Breakfast Available
  • 7:50 AM - 8:00 AM (CDT)
    Welcome Remarks
    Jose Eugenio Najera, MD

    Jose Eugenio Najera, MD

    OSCO President

  • 8:00 AM - 9:00 AM (CDT)
    Ductal Carcinoma in Situ (DCIS)
    Anna Beck, MD

    Anna Beck, MD

    Breast Surgical Oncology Fellow

    Memorial Sloan Kettering Cancer Center New York City, NY

  • 9:00 AM - 9:15 AM (CDT)
    Refreshment Break
  • 9:15 AM - 10:15 AM
    Post Neoadjuvant Therapy for TNBC
    Heather McArthur, MD, MPH

    Heather McArthur, MD, MPH

    Clinical Director of the Breast Cancer Program

    Simmons Cancer Center UT Southwestern Medical Center Dallas, TX

  • 10:15 AM - 10:30 AM (CDT)
    Refreshment Break
  • 10:30 AM-11:30 AM (CDT)
    Challenges in Treating ER+ Breast Cancer
    Virginia Kaklamani, MD, DSc

    Virginia Kaklamani, MD, DSc

    Professor of Medicine, Breast Oncology Program

    MD Anderson Cancer Center UT Health San Antonio, TX

  • 11:30 AM - 11:45 AM (CDT)
    Refreshment Break
  • 11:45 AM - 12:45 PM (CDT)
    HER2 Low/Zero Clinical and Molecular Characteristics
    Adam Brufsky, MD, PhD

    Adam Brufsky, MD, PhD

    Professor of Medicine

    University of Pittsburgh Pittsburg, PA

  • 12:45 PM (CST)